Technical Demonstration of Whole Genome Array Comparative Genomic Hybridization
August 5th, 2008
12.6K views
This video is a technical demonstration of the hybridization protocol for whole genome tiling path array CGH, which scans the entire human genome using only 25-100 ng of DNA that can be isolated from a variety of sources, including archival formalin fixed material.
*The slides can remain in the
View the full transcript and gain access to thousands of scientific videos
Overview
This video demonstrates the hybridization protocol for a whole genome tiling path array CGH, enabling the scanning of the entire human genome with minimal DNA input. The method allows for the analysis of various sample types, including archival materials.
Key Study Components
Area of Science
- Genomics
- DNA Analysis
- Hybridization Techniques
Background
- The array consists of 26,946 individually sequenced back clones.
- Each slide contains a total of 54,000 elements.
- Data obtained is comparable to high-density oligo arrays.
- Bioinformatics interpretation is not required for data analysis.
Purpose of Study
- To demonstrate a hybridization protocol for genome scanning.
- To utilize minimal DNA samples for comprehensive genomic analysis.
- To facilitate the use of diverse sample types in genomic studies.
Methods Used
- Hybridization protocol for whole genome tiling path array CGH.
- Use of 25-100 ng of DNA from various sources.
- Application of back clones spotted in duplicate on slides.
- Analysis of samples without amplification.
Main Results
- Successful scanning of the human genome with low DNA input.
- Ability to analyze DNA from blood, frozen tissue, and FFPE material.
- Data quality comparable to higher density arrays.
- Facilitated analysis without extensive bioinformatics requirements.
Conclusions
- The hybridization protocol is effective for genome-wide analysis.
- Minimal DNA requirements broaden the scope of sample types.
- This method enhances accessibility for genomic research.
Frequently Asked Questions
What is the main advantage of this hybridization protocol?
The main advantage is the ability to use as little as 100 ng of DNA, allowing for analysis of various sample types without amplification.
What types of samples can be analyzed?
Samples include DNA from blood, frozen tissues, sorted cells, and archival FFPE material.
How does this method compare to high-density oligo arrays?
The data obtained is comparable, but this method does not require complex bioinformatics interpretation.
What is the size of the array used in this protocol?
The array is composed of 26,946 individually sequenced back clones printed on a single slide.
How many elements are printed on each slide?
A total of 54,000 elements are printed in duplicate on each slide.
Is amplification of DNA necessary for this protocol?
No, amplification is not necessary, allowing for direct analysis of low DNA quantities.
Executive Industry Relevance
Array CGH enables genome-wide detection of DNA copy number alterations with minimal input, supporting target validation in oncology and genetic disease research. The method reduces dependency on bioinformatics expertise while maintaining data quality comparable to high-density arrays. This facilitates broader adoption in discovery pipelines where sample scarcity and heterogeneity are common challenges.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of genomic alterations across the whole genome to support target hypothesis testing.
- Operational Value: Works with as little as 25-100 ng of unamplified DNA, allowing use of precious or archival samples.
- Predictive Value: Detects alterations as small as 50 kb, providing resolution for early-stage mechanistic de-risking.
Screening & Assay Development
- Scientific Value: Generates quantitative log2 ratio data at each BAC target for objective comparison of sample and reference genomes.
- Operational Value: Uses SeeGH software to process 53,892 data points per experiment, standardizing output for downstream analysis.
- Reproducibility: Duplicate spotting of BAC clones enhances signal reliability and reduces technical variability.
Translational & Preclinical Research
- Translational Continuity: Compatible with FFPE DNA, enabling use of clinically relevant, archival patient samples.
- Tissue Heterogeneity Tolerance: Large BAC insert size reduces need for microdissection, supporting analysis of complex tissue samples.
- Preclinical Modeling: Detects DNA gains, losses, amplifications, and homozygous deletions relevant to disease modeling.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target identification to preclinical validation, particularly when genomic alterations inform mechanistic understanding.
- Discovery Biology: Supports hypothesis-driven screening for copy number changes linked to oncogenes or tumor suppressors.
- Analytics: Produces chromosomal position-aligned log2 ratios that enable visual and quantitative assessment of genomic instability.
- Enterprise Reuse: Protocol is standardized and reusable across labs, with minimal need for specialized bioinformatics support.
Operational & Enterprise Impact
- Scientific Value: High-resolution detection of DNA alterations aids in target confidence and pathway clarification.
- Operational Value: Low DNA input and tolerance for impure samples increase accessibility and reduce preprocessing burden.
- Strategic Value: Enables go/no-go decisions based on genomic profiles without requiring sequencing infrastructure.
- Portfolio Impact: Facilitates risk-adjusted prioritization of targets with validated genomic alterations.
Implementation Considerations
- Requires expertise in nucleic acid labeling, hybridization, and fluorescence detection.
- Dependent on hybridization cassettes, temperature-controlled incubators, and microarray scanners.
- NanoDrop quantification is essential for assessing DNA quality and dye incorporation efficiency.
- Protocol optimization needed for varying sample types, including FFPE and low-input materials.
- Ambient ozone levels must be monitored during scanning to prevent Cy5 dye degradation.
Biopharma FAQs
Why is independent variable isolation important in array CGH experiments?
Isolating the test and reference DNA samples ensures that observed signal ratios reflect true genomic differences rather than technical variation, which is critical for accurate target validation in discovery workflows.
How does quantitative dependent variable measurement enable copy number analysis?
The log2 signal intensity ratio between Cy3- and Cy5-labeled DNA at each BAC target provides a quantitative readout of gain or loss, enabling objective assessment of genomic alterations across the genome.
Why do replication requirements matter for cross-functional collaboration in array CGH?
Duplicate spotting of BAC clones on the array increases measurement reliability, allowing teams to trust data consistency when translating findings between discovery, preclinical, and translational groups.
What statistical analysis capabilities are required before implementing array CGH in a discovery pipeline?
Teams must be able to process and visualize log2 ratio data using tools like SeeGH to identify significant deviations from baseline, which supports confident interpretation of copy number events without requiring advanced bioinformatics expertise.
Why does null hypothesis testing matter for target validation using array CGH?
Applying statistical thresholds to log2 ratios helps distinguish true copy number alterations from noise, ensuring that only biologically relevant genomic changes are pursued as potential drug targets.
